Endogenous Interferences in Clinical Laboratory Tests : Icteric, Lipemic and Turbid Samples

Kroll, Martin H.; Mccudden, Christopher R.

ISBN 10: 3110266202 ISBN 13: 9783110266207
Published by De Gruyter, 2012
New Hardcover

From GreatBookPricesUK, Woodford Green, United Kingdom Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

AbeBooks Seller since January 28, 2020

This specific item is no longer available.

About this Item

Description:

Seller Inventory # 19111566-n

Report this item

Synopsis:

The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests.

Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact.

Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety.

About the Author:

Martin H. Kroll, Boston University, Massachusetts, USA; Christopher R. McCudden, University of Ottawa, Ontario, Canada; University of North Carolina at Chapel Hill, USA.

"About this title" may belong to another edition of this title.

Bibliographic Details

Title: Endogenous Interferences in Clinical ...
Publisher: De Gruyter
Publication Date: 2012
Binding: Hardcover
Condition: New

Top Search Results from the AbeBooks Marketplace

Stock Image

Martin H. Kroll
Published by De Gruyter, 2012
ISBN 10: 3110266202 ISBN 13: 9783110266207
New Hardcover

Seller: PBShop.store UK, Fairford, GLOS, United Kingdom

Seller rating 4 out of 5 stars 4-star rating, Learn more about seller ratings

HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # FW-9783110266207

Contact seller

Buy New

US$ 37.92
US$ 5.60 shipping
Ships from United Kingdom to U.S.A.

Quantity: 15 available

Add to basket

Stock Image

Kroll, Martin H./ Mccudden, Christopher R.
Published by De Gruyter, 2012
ISBN 10: 3110266202 ISBN 13: 9783110266207
New Paperback

Seller: Revaluation Books, Exeter, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Paperback. Condition: Brand New. 1st edition. 143 pages. 9.25x6.75x0.50 inches. In Stock. Seller Inventory # __3110266202

Contact seller

Buy New

US$ 38.40
US$ 16.82 shipping
Ships from United Kingdom to U.S.A.

Quantity: 2 available

Add to basket

Seller Image

Martin H. Kroll|Christopher R. McCudden
Published by De Gruyter, 2012
ISBN 10: 3110266202 ISBN 13: 9783110266207
New Hardcover
Print on Demand

Seller: moluna, Greven, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Seller Inventory # 4456359

Contact seller

Buy New

US$ 38.87
US$ 57.01 shipping
Ships from Germany to U.S.A.

Quantity: Over 20 available

Add to basket

Stock Image

Kroll, Martin H.
Published by De Gruyter, 2012
ISBN 10: 3110266202 ISBN 13: 9783110266207
New Hardcover

Seller: Brook Bookstore On Demand, Napoli, NA, Italy

Seller rating 3 out of 5 stars 3-star rating, Learn more about seller ratings

Condition: new. Seller Inventory # 5d8669fdd77f13faa1be04171c1d8ac5

Contact seller

Buy New

US$ 39.96
US$ 6.40 shipping
Ships from Italy to U.S.A.

Quantity: Over 20 available

Add to basket

Stock Image

Kroll, Martin H.
Published by De Gruyter 2017-09, 2017
ISBN 10: 3110266202 ISBN 13: 9783110266207
New Hardcover

Seller: Chiron Media, Wallingford, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

PF. Condition: New. Seller Inventory # 6666-IUK-9783110266207

Contact seller

Buy New

US$ 41.48
US$ 20.84 shipping
Ships from United Kingdom to U.S.A.

Quantity: 10 available

Add to basket

Seller Image

Christopher R. Mccudden
Published by De Gruyter, De Gruyter, 2012
ISBN 10: 3110266202 ISBN 13: 9783110266207
New Taschenbuch

Seller: AHA-BUCH GmbH, Einbeck, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact. Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety. Seller Inventory # 9783110266207

Contact seller

Buy New

US$ 41.89
US$ 71.44 shipping
Ships from Germany to U.S.A.

Quantity: 1 available

Add to basket

Seller Image

Christopher R. Mccudden
Published by De Gruyter Dez 2012, 2012
ISBN 10: 3110266202 ISBN 13: 9783110266207
New Taschenbuch
Print on Demand

Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact. Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety. 156 pp. Englisch. Seller Inventory # 9783110266207

Contact seller

Buy New

US$ 41.89
US$ 26.76 shipping
Ships from Germany to U.S.A.

Quantity: 2 available

Add to basket

Seller Image

Christopher R. Mccudden
ISBN 10: 3110266202 ISBN 13: 9783110266207
New Taschenbuch
Print on Demand

Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests.Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact.Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety.Walter de Gruyter, Genthiner Straße 13, 10785 Berlin 156 pp. Englisch. Seller Inventory # 9783110266207

Contact seller

Buy New

US$ 41.89
US$ 69.82 shipping
Ships from Germany to U.S.A.

Quantity: 1 available

Add to basket

Seller Image

Christopher R. Mccudden (u. a.)
Published by De Gruyter, 2012
ISBN 10: 3110266202 ISBN 13: 9783110266207
New Taschenbuch

Seller: preigu, Osnabrück, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. Endogenous Interferences in Clinical Laboratory Tests | Icteric, Lipemic and Turbid Samples | Christopher R. Mccudden (u. a.) | Taschenbuch | Patient Safety | XII | Englisch | 2012 | De Gruyter | EAN 9783110266207 | Verantwortliche Person für die EU: Walter de Gruyter GmbH, De Gruyter GmbH, Genthiner Str. 13, 10785 Berlin, productsafety[at]degruyterbrill[dot]com | Anbieter: preigu. Seller Inventory # 106521685

Contact seller

Buy New

US$ 42.67
US$ 81.46 shipping
Ships from Germany to U.S.A.

Quantity: 5 available

Add to basket

Seller Image

Martin H. Kroll, Christopher R. McCudden
Published by De Gruyter, DE, 2012
ISBN 10: 3110266202 ISBN 13: 9783110266207
New Hardcover

Seller: Rarewaves USA, OSWEGO, IL, U.S.A.

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Hardback. Condition: New. The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact. Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety. Seller Inventory # LU-9783110266207

Contact seller

Buy New

US$ 43.20
Free Shipping
Ships within U.S.A.

Quantity: Over 20 available

Add to basket

There are 6 more copies of this book

View all search results for this book